Smofkabiven 1.14 g (Soybean Oil EMULSION) 1.14 G

SMOFKABIVEN 1.14 G is a soybean oil-based intravenous emulsion designed for nutritional support. This product, manufactured by Fresenius Kabi Canada Ltd., provides essential fatty acids and calories for patients requiring parenteral nutrition.

Strength

1.14 G

Pack Size

986/1477/1970/2463ML

Manufacturer / TM Owner

FRESENIUS KABI CANADA LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

SMOFKABIVEN 1.14 G is used to provide nutritional support for patients who cannot absorb nutrients through the digestive system. This intravenous emulsion contains soybean oil, which supplies essential fatty acids and calories. It is often used in clinical settings to support patients who require parenteral nutrition due to various medical conditions.

Side Effects

When administered intravenously, SMOFKABIVEN 1.14 G provides essential fatty acids and calories to support overall health. It helps maintain proper nutritional balance in patients who cannot consume food orally. The emulsion is designed to be well-tolerated, but individual responses may vary.

Precautions & Warnings

SMOFKABIVEN 1.14 G should be administered under medical supervision. It is important to follow proper handling and storage guidelines to ensure the emulsion remains effective. Patients with known allergies to soybean oil or any of the components should avoid using this product.

Avoid Interactions

SMOFKABIVEN 1.14 G may interact with other medications or supplements. It is important to inform healthcare providers about all current medications before starting this treatment. Additionally, compatibility with other intravenous solutions should be checked to avoid potential interactions.

Frequently Asked Questions

SMOFKABIVEN 1.14 G is used to provide nutritional support for patients who cannot absorb nutrients through the digestive system.

SMOFKABIVEN 1.14 G is administered intravenously under medical supervision.

SMOFKABIVEN 1.14 G provides essential fatty acids and calories to support overall health in patients requiring parenteral nutrition.

SMOFKABIVEN 1.14 G should be administered under medical supervision and proper handling guidelines should be followed.

SMOFKABIVEN 1.14 G may interact with other medications or supplements, so it is important to inform healthcare providers about all current medications.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.